Idera Pharmaceuticals reported $2.47M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbott ABT:US $ 2.79B 7M
Aceto ACET:US 5.02M 605K
Agenus AGEN:US $ 16.65M 298K
Alnylam Pharmaceuticals ALNY:US $ 153.82M 1.08M
Amgen AMGN:US $ 1.38B 130M
Biogen BIIB:US $ 637.3M 42.3M
Biomarin Pharmaceutical BMRN:US $ 184.16M 9.84M
Cytrx CYTR:US 1.18M 99K
Dynavax Technologies DVAX:US $ 21.08M 862K
Eli Lilly And LLY:US $ 1.69B 109.7M
Gilead Sciences GILD:US $ 1.34B 297M
GlaxoSmithKline GSK:LN 2.5B 183M
Idera Pharmaceuticals IDRA:US $ 2.47M 684K
Merk MRK:US $ 2.25B 376M
Mirati Therapeutics MRTX:US $ 29.61M 1.26M
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Pfizer PFE:US $ 2.79B 134M
Sarepta Therapeutics SRPT:US $ 72.35M 1.22M
Seattle Genetics SGEN:US $ 165.13M 5.29M
Ultragenyx Pharmaceutical RARE:US $ 53.41M 152K
X T L Biopharmaceuticals XTLB:US 245K 40K